Stefan
Beyer, PhD

Stefan
Beyer, PhD
Chairman
Stefan is an Executive Advisor at Ampersand Capital Partners, a healthcare-focused growth equity firm with over $3 billion under management.
With more than 20 years of leadership and business development experience within the life sciences sector, Stefan served as CEO and later President of Vibalogics, an Ampersand portfolio company acquired by Recipharm in 2022. Under his leadership, Vibalogics became a leading global CDMO, specializing in the production of oncolytic viral vectors and viral vector vaccines.
Stefan brings extensive experience in transforming family-owned businesses into investor-driven growth companies.
He holds a Ph.D. in biology and biotechnology, with a focus on the molecular biology of natural product-producing microorganisms.